Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Werner

Showing results (111-120 of 151) with videos related to

Pageof 16
Sort By:
Journal for Immunotherapy of Cancer|December 28, 2020
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of lymphomaSattva S Neelapu, Sherry Adkins, Stephen M Ansell, et al.
Cancers|December 23, 2020
FET PET Radiomics for Differentiating Pseudoprogression from Early Tumor Progression in Glioma Patients Post-ChemoradiationPhilipp Lohmann, Mai A Elahmadawy, Robin Gutsche, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 4, 2025
Diagnosis of treatment-related changes in children and adolescents with brain and spinal tumors: a cost-effectiveness analysis using MRI and [18 F]FET PETJurij Rosen, Jan-Michael Werner, Garry S Ceccon, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 7, 2020
Early Treatment Response Assessment Using <sup>18</sup>F-FET PET Compared with Contrast-Enhanced MRI in Glioma Patients After Adjuvant Temozolomide ChemotherapyGarry Ceccon, Philipp Lohmann, Jan-Michael Werner, et al.
American Journal of Hematology|September 2, 2022
Use of CYP3Ai and impact on outcomes in patients with acute myeloid leukemia treated with venetoclax plus azacitidine in the VIALE-A studyBrian A Jonas, Courtney DiNardo, Nicola Fracchiolla, et al.
Neuro-Oncology|March 24, 2023
Multimodal imaging findings in patients with glioblastoma with extensive coagulative necrosis related to regorafenibJan-Michael Werner, Michael M Wollring, Caroline Tscherpel, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 2, 2020
Flare Phenomenon in <i>O</i>-(2-<sup>18</sup>F-Fluoroethyl)-l-Tyrosine PET After Resection of GliomasChristian P Filss, Ann K Schmitz, Gabriele Stoffels, et al.
Plos One|February 6, 2013
A telomerase immortalized human proximal tubule cell line with a truncation mutation (Q4004X) in polycystin-1Brittney-Shea Herbert, Brenda R Grimes, Wei Min Xu, et al.
Radiology|July 23, 2024
Monitoring Patients with Glioblastoma by Using a Large Language Model: Accurate Summarization of Radiology Reports with GPT-4Kai R Laukamp, Robert A Terzis, Jan-Michael Werner, et al.
American Journal of Hematology|September 2, 2022
Postremission cytopenia management in patients with acute myeloid leukemia treated with venetoclax and azacitidine in VIALE-AKeith W Pratz, Courtney D DiNardo, Dominik Selleslag, et al.
Pageof 16

Showing results (111-120 of 151) with videos related to

Sort By:
Pageof 16
Journal for Immunotherapy of Cancer|December 28, 2020
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of lymphomaSattva S Neelapu, Sherry Adkins, Stephen M Ansell, et al.
Cancers|December 23, 2020
FET PET Radiomics for Differentiating Pseudoprogression from Early Tumor Progression in Glioma Patients Post-ChemoradiationPhilipp Lohmann, Mai A Elahmadawy, Robin Gutsche, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 4, 2025
Diagnosis of treatment-related changes in children and adolescents with brain and spinal tumors: a cost-effectiveness analysis using MRI and [18 F]FET PETJurij Rosen, Jan-Michael Werner, Garry S Ceccon, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 7, 2020
Early Treatment Response Assessment Using <sup>18</sup>F-FET PET Compared with Contrast-Enhanced MRI in Glioma Patients After Adjuvant Temozolomide ChemotherapyGarry Ceccon, Philipp Lohmann, Jan-Michael Werner, et al.
American Journal of Hematology|September 2, 2022
Use of CYP3Ai and impact on outcomes in patients with acute myeloid leukemia treated with venetoclax plus azacitidine in the VIALE-A studyBrian A Jonas, Courtney DiNardo, Nicola Fracchiolla, et al.
Neuro-Oncology|March 24, 2023
Multimodal imaging findings in patients with glioblastoma with extensive coagulative necrosis related to regorafenibJan-Michael Werner, Michael M Wollring, Caroline Tscherpel, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 2, 2020
Flare Phenomenon in <i>O</i>-(2-<sup>18</sup>F-Fluoroethyl)-l-Tyrosine PET After Resection of GliomasChristian P Filss, Ann K Schmitz, Gabriele Stoffels, et al.
Plos One|February 6, 2013
A telomerase immortalized human proximal tubule cell line with a truncation mutation (Q4004X) in polycystin-1Brittney-Shea Herbert, Brenda R Grimes, Wei Min Xu, et al.
Radiology|July 23, 2024
Monitoring Patients with Glioblastoma by Using a Large Language Model: Accurate Summarization of Radiology Reports with GPT-4Kai R Laukamp, Robert A Terzis, Jan-Michael Werner, et al.
American Journal of Hematology|September 2, 2022
Postremission cytopenia management in patients with acute myeloid leukemia treated with venetoclax and azacitidine in VIALE-AKeith W Pratz, Courtney D DiNardo, Dominik Selleslag, et al.
Pageof 16